Eric M. Jurgens, Ross S. Firestone, Jagrutiben Chaudhari, Kinga Hosszu, Sean M. Devlin, Urvi A. Shah, Jonathan Landa, Devin P. McAvoy, Alexander M. Lesokhin, Neha Korde, Hani Hassoun, Carlyn R. Tan, Malin Hultcrantz, Gunjan L. Shah, Heather J. Landau, David J. Chung, Michael Scordo, Ozgur Can Eren, Ahmet Dogan, Sergio A. Giralt, Jae H. Park, Isabelle Rivière, Renier J. Brentjens, Eric L. Smith, Xiuyan Wang, Saad Z. Usmani, Sham Mailankody. "Phase I Trial of MCARH109, a G Protein–Coupled Receptor Class C Group 5 Member D (GPRC5D)–Targeted Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma: An Updated Analysis." Journal of Clinical Oncology, 2025. doi:10.1200/jco-24-01785